Addex Therapeutics Ltd announced that it has completed the equity financing transaction entered into on April 3, 2023 with a leading institutional healthcare investor, pursuant to which the Company sold 7,999,998 shares in the form of 1,333,333 American Depositary Shares at a gross purchase price of $0.95 per ADS.
